Benjamin Ellezam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin Ellezam has a total of 447 co-authors. Here are the top co-authors by number of shared publications:
- Nada Jabado
Department of Human Genetics, McGill University, Montreal, Canada
60 shared publications - David T.W. Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
53 shared publications - Claudia L. Kleinman
Lady Davis Research Institute, Jewish General Hospital, Montréal, Canada
47 shared publications - Michael D. Taylor
Texas Children’s Hospital, Baylor College of Medicine , Houston, Texas
47 shared publications - Selin Jessa
Department of Genetics, Stanford University, Stanford, CA, USA
46 shared publications - Manav Pathania
Department of Oncology and The Milner Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK
45 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Reference dataset labels used for cell type annotation of mouse model single-cell datasets.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Reference dataset labels used for cell type annotation of mouse model single-cell datasets.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Quality control (QC) metrics and copy-number variation for scRNAseq datasets of NB-FOXR2 patient tumors.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Quality control (QC) metrics and copy-number variation for scRNAseq datasets of NB-FOXR2 patient tumors.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Summary of patient samples included in this study, and profiling by RNAseq, scRNAseq, or scMultiome.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Summary of patient samples included in this study, and profiling by RNAseq, scRNAseq, or scMultiome.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Quality control metrics and processing parameters for single-cell data for patient tumors.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Quality control metrics and processing parameters for single-cell data for patient tumors.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
NB-FOXR2 tumors transcriptionally resemble interneurons and oligodendrocyte precursor cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
NB-FOXR2 tumors transcriptionally resemble interneurons and oligodendrocyte precursor cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 8 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Quantification of expression and detection rate (Pct1) for transcription factors in the normal brain reference datasets.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 8 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Quantification of expression and detection rate (Pct1) for transcription factors in the normal brain reference datasets.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Cell type specific gene signatures derived from reference datasets, used for enrichment scoring.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 9 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Cell type specific gene signatures derived from reference datasets, used for enrichment scoring.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Orthotopic engraftment of cell lines derived from Foxr2 p53LOF murine model.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Orthotopic engraftment of cell lines derived from Foxr2 p53LOF murine model.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
NB-FOXR2 express a transcription factor fingerprint of the medial ganglionic eminence.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
NB-FOXR2 express a transcription factor fingerprint of the medial ganglionic eminence.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Cell type specific gene signatures derived from reference datasets, used for enrichment scoring.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 9 from FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Cell type specific gene signatures derived from reference datasets, used for enrichment scoring.